Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foquest in Adults ≥ 65 Years With ADHD
NCT07710014Phase 4Recruiting
- Sponsor
- DAR Clinical Research
- Start
- Oct 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by DAR Clinical Research. Started Oct 2026; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT07710014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710014.